Pediatric phase i trial design using maximum target inhibition as the primary endpoint
Document Type
Journal Article
Publication Date
2010
Journal
J.Natl.Cancer Inst.
Volume
102
Issue
12
Inclusive Pages
909-912
APA Citation
Meany, H., Balis, F., Aikin, A., Whitcomb, P., & Murphy, R. (2010). Pediatric phase i trial design using maximum target inhibition as the primary endpoint. J.Natl.Cancer Inst., 102 (12). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs/5251
COinS